Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey
- 814 Downloads
The purpose of this study was to identify the treatment-associated problems that most impact on patients undergoing cancer chemotherapy, how problems relate to experiences of supportive care and variations in experience between cancer treatment centres.
A survey administered to patients at six cancer centres in England explored variations of prevalence of 17 cancer chemotherapy-associated problems and associated supportive care. Problem items were identified as the most frequently experienced and severe when experienced in a scoping and consensus exercise. A health-related quality of life (HRQoL) measure, the EQ5D, was included to measure impact of problems.
A total of 363 completed questionnaires were returned (response rate 43 %, median 61 %). The most prevalent problem was ‘tiredness/fatigued’ (90 %), followed by ‘changes in taste & smell’ (69 %) and ‘difficulty managing everyday tasks’ (61 %). Significant variations in problem prevalence existed between centres, and some common problems were rarely reported in the literature. Regression analysis found that almost all problems were significantly associated with HRQoL, with social/emotional problems having as much impact on HRQoL as physical/psychological side effects of treatment. Greatest effect size was for difficulty managing everyday tasks. Respondents reported significant variations in supportive care between centres, with more supportive care received for physical/psychological problems than for social/emotional problems. Findings indicated that patients who received increased supportive care experienced less severe problems.
The most common and distressing chemotherapy-associated problems were identified. These problems are mitigated by quality supportive care. Routine measurement and monitoring of problem items and supportive care are warranted to facilitate benchmarking and service improvements both within and between cancer centres.
KeywordsCancer Supportive care Treatment-associated problems Health-related quality of life (HRQoL)
The study was funded by the National Cancer Action Team (NCAT). We would like to thank all the patients and staff at each of the six cancer centres who participated and made this project possible. In particular, we would like to thank the staff members who coordinated the distribution and collection of the pilot survey questionnaires: Michael Flynn, Bernie Wilson, Jeanette Ribton, Belinda Mills and Amanda Tonge. We would also like to thank Geoff Pike of Employment Research Ltd. for assisting with analysis.
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare. All data remains the property of the authors, and results were not subject to approval by any funding body.
- 1.Systematic Anti-Cancer Therapy Chemotherapy Dataset 2015 http://www.chemodataset.nhs.uk/home (accessed 20/10/2015).
- 2.Brédart A, Kop L-J, Efficace F, Beaudeau A, Brito T, Dolbeault S, Aaronson N, EORTC Quality of Life Group (2014) Quality of care in the oncology outpatient setting from patients’ perspective: a systematic review of questionnaires’ content and psychometric performance. Psycho-Oncology. doi: 10.1002/pon.3661. Google Scholar
- 3.Watson DE, Mooney D, Peterson S (2007) Patients experiences with ambulatory cancer care in British Columbia, 2005/06. University of British Columbia Health Services and Policy Research.Google Scholar
- 4.Arraras JI, Illarramendi JJ, Viudez A, Lecumberri MJ, de la Cruz S, Hernandez B, Zarandona U, et al. (2012) The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUTPATSAT35 CT: a validation study for Spanish patients. Support Care Cancer 20:3269–3278CrossRefPubMedGoogle Scholar
- 11.National Council for Hospice and Specialist Palliative Care Services 2002 Definitions of supportive and palliative care: a consultation paper national council for hospice and specialist palliative care servicesGoogle Scholar
- 12.Gerteis M, Edgman-Levitan S, Daley J (1993) Through the patient’s eyes. Understanding and promoting patient-centered care. Jossey-Bass, San Francisco, CAGoogle Scholar
- 13.National Institute for Clinical Excellence (2003) Improving supportive and palliative care for adults with cancer. National Institute for Clinical Excellence, LondonGoogle Scholar
- 14.National Comprehensive Cancer Network (2008) Distress management clinical practice guidelines. J. Natl Compr Cancer Netw 1.Google Scholar
- 19.Kaufman PA, Mayer M, Dreyer NA, Yeun MY, Yu E, Zhaohui S, Mun Y, Sloan JA, Cleeland CS (2012) Patient reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS). J Clin Oncol 28:6138Google Scholar
- 22.Mort D, Lansdown M, Smith N (2008) For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy (report by the national confidential enquiry into patient outcome and death). NCEPOD.Google Scholar
- 25.Ekwall E, Ternestedt B-M, Sorbe B, Graneheim UH (2011) Patients’ perceptions of communication with the health care team during chemotherapy for the first recurrence of ovarian cancer. Eur J Oncol Nurs, 53–58.Google Scholar
- 27.Quality Health (2014). Cancer Patient Experience Survey 2012–13: National Report. https://www.quality-health.co.uk/resources/surveys/national-cancer-experience-survey/2013-national-cancer-patient-exerience-survey/2014-national-cancer-patient-experience-survey-reports (Accessed 26/06/2015).
- 29.Department of Health, Macmillan Cancer Support, NHS Improvement. The National Cancer Survivorship Initiative Vision. Department of Health, 2010. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_111230 (accessed 20 Sept 2015).
- 31.NHS England (2014) GP Patient Survey http://www.england.nhs.uk/statistics/2015/01/08/gp-patient-survey-2014/ (accessed May 25 2015).
- 32.AM G, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MHN (1996) On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195Google Scholar